| Michael John Pearce, MD | |
|
1055 N 300 W, Suite 500, Provo, UT 84604-3344 | |
| (801) 357-7291 | |
| (801) 357-9719 |
| Full Name | Michael John Pearce |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 35 Years |
| Location | 1055 N 300 W, Provo, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568478832 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 901829361205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Utah Valley Hospital | Provo, UT | Hospital |
| American Fork Hospital | American fork, UT | Hospital |
| Sevier Valley Hospital | Richfield, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
The Pan American Health Organization (PAHO) and the University of Geneva have signed an agreement to increase and facilitate cooperation on emergency preparedness and disaster relief programs.
UT Southwestern Medical Center plastic surgeons and specialists in diabetes, neurology, pain management and rehabilitation are launching a cutting-edge study of peripheral nerve surgery to alleviate long-standing pain and numbness in patients with diabetic neuropathy.
St. Jude Medical, Inc., a global medical device company and an international leader in chronic pain therapy development, today announced the European launch of the Proclaim™ Elite Spinal Cord Stimulation System, the first and only upgradeable and non-rechargeable spinal cord stimulation (SCS) system approved to deliver burst stimulation from St. Jude Medical
Incyte Corporation, Results from a Phase I/II study of Incyte's janus kinase (JAK) inhibitor with the investigational name INCB18424 (also known as INCB018424 and INC424) were published today in The New England Journal of Medicine, demonstrating marked and durable clinical benefits in patients with myelofibrosis.
Micronics, Inc., a leading developer of point-of-care molecular diagnostic products, announced today that it has entered into a license agreement with Biosearch Technologies, Inc. (Biosearch) for the right to make, have made, use and sell Micronics' products that incorporate Biosearch's proprietary fluorophores and quencher dyes for nucleic acid assays. Under the terms of the worldwide license, Biosearch has granted Micronics a royalty-free use of certain of its chemistries for inclusion in Micronics' infectious disease tests for sale in underdeveloped countries.
› Verified 6 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
The Pan American Health Organization (PAHO) and the University of Geneva have signed an agreement to increase and facilitate cooperation on emergency preparedness and disaster relief programs.
UT Southwestern Medical Center plastic surgeons and specialists in diabetes, neurology, pain management and rehabilitation are launching a cutting-edge study of peripheral nerve surgery to alleviate long-standing pain and numbness in patients with diabetic neuropathy.
St. Jude Medical, Inc., a global medical device company and an international leader in chronic pain therapy development, today announced the European launch of the Proclaim™ Elite Spinal Cord Stimulation System, the first and only upgradeable and non-rechargeable spinal cord stimulation (SCS) system approved to deliver burst stimulation from St. Jude Medical
Incyte Corporation, Results from a Phase I/II study of Incyte's janus kinase (JAK) inhibitor with the investigational name INCB18424 (also known as INCB018424 and INC424) were published today in The New England Journal of Medicine, demonstrating marked and durable clinical benefits in patients with myelofibrosis.
Micronics, Inc., a leading developer of point-of-care molecular diagnostic products, announced today that it has entered into a license agreement with Biosearch Technologies, Inc. (Biosearch) for the right to make, have made, use and sell Micronics' products that incorporate Biosearch's proprietary fluorophores and quencher dyes for nucleic acid assays. Under the terms of the worldwide license, Biosearch has granted Micronics a royalty-free use of certain of its chemistries for inclusion in Micronics' infectious disease tests for sale in underdeveloped countries.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael John Pearce, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (801) 357-7291 | Michael John Pearce, MD 1055 N 300 W, Suite 500, Provo, UT 84604-3344 Ph: (801) 357-7291 |
News Archive
The Pan American Health Organization (PAHO) and the University of Geneva have signed an agreement to increase and facilitate cooperation on emergency preparedness and disaster relief programs.
UT Southwestern Medical Center plastic surgeons and specialists in diabetes, neurology, pain management and rehabilitation are launching a cutting-edge study of peripheral nerve surgery to alleviate long-standing pain and numbness in patients with diabetic neuropathy.
St. Jude Medical, Inc., a global medical device company and an international leader in chronic pain therapy development, today announced the European launch of the Proclaim™ Elite Spinal Cord Stimulation System, the first and only upgradeable and non-rechargeable spinal cord stimulation (SCS) system approved to deliver burst stimulation from St. Jude Medical
Incyte Corporation, Results from a Phase I/II study of Incyte's janus kinase (JAK) inhibitor with the investigational name INCB18424 (also known as INCB018424 and INC424) were published today in The New England Journal of Medicine, demonstrating marked and durable clinical benefits in patients with myelofibrosis.
Micronics, Inc., a leading developer of point-of-care molecular diagnostic products, announced today that it has entered into a license agreement with Biosearch Technologies, Inc. (Biosearch) for the right to make, have made, use and sell Micronics' products that incorporate Biosearch's proprietary fluorophores and quencher dyes for nucleic acid assays. Under the terms of the worldwide license, Biosearch has granted Micronics a royalty-free use of certain of its chemistries for inclusion in Micronics' infectious disease tests for sale in underdeveloped countries.
› Verified 6 days ago
Dr. Christopher Gordon, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 745 N 500 W Ste 200, Provo, UT 84601 Phone: 801-375-9292 Fax: 801-375-9290 | |
Daniel N. Bennett, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1055 N 500 W, Ste 101, Building C, Provo, UT 84604 Phone: 801-373-4366 | |
Dr. Christopher Ryan Lew, DO Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-960-7558 | |
Albert Rivero, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1134 N 500 W Ste 101, Provo, UT 84604 Phone: 801-357-8310 | |
Dr. Wenshu Yu, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3650 N University Ave Ste 150, Provo, UT 84604 Phone: 801-818-1940 Fax: 801-818-1945 | |
William T. Stephenson Ii, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 395 W Bulldog Blvd Ste 103, Provo, UT 84604 Phone: 801-357-8200 Fax: 801-357-8201 | |
Gregory E Craner, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1055 N 500 W, Suite 100 Bldg B, Provo, UT 84604 Phone: 801-374-1268 Fax: 801-429-8041 |